QC
TMCI icon

Quadrature Capital’s Treace Medical Concepts TMCI Stock Holding History

Quadrature Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.6K Sell
32,552
-28,092
-46% -$56K ﹤0.01% 1287
2025
Q4 		$149K Buy
+60,644
New +$263K ﹤0.01% 1030

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrature Capital's TMCI Position: Q1 2026 in Review

Quadrature Capital reduced its Treace Medical Concepts (TMCI) stake by 46% in Q1 2026, selling an estimated $56K and leaving 32,552 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Quadrature Capital first reported a position in TMCI in Q4 2025 and has held it in 2 quarters since. The position peaked at $149K in Q4 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Quadrature Capital held 32,552 shares of Treace Medical Concepts worth $43.6K as of Q1 2026.
  • Quadrature Capital sold 28,092 Treace Medical Concepts shares in Q1 2026, an estimated $56K.
  • Treace Medical Concepts made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1287 holding.
  • Quadrature Capital first reported a position in Treace Medical Concepts in Q4 2025 and has held it in 2 quarters since.
  • Quadrature Capital's Treace Medical Concepts position peaked at $149K in Q4 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.